Pelvic Lymphadenectomy in Bladder Cancer Treatment
Author Information
Author(s): Ehab A. Elzayat, Ali A. Al-Zahrani
Primary Institution: Al-Azhar University, Cairo, Egypt
Hypothesis
What is the therapeutic and prognostic value of pelvic lymphadenectomy in invasive bladder cancer?
Conclusion
Pelvic lymphadenectomy is essential for staging and improving outcomes in bladder cancer surgery.
Supporting Evidence
- Pelvic lymphadenectomy is associated with better cancer control and prognosis.
- Extended lymphadenectomy improves survival rates without increasing morbidity.
- Patients with more lymph nodes removed tend to have better outcomes.
Takeaway
When doctors remove lymph nodes during bladder cancer surgery, it helps them understand how serious the cancer is and can improve the chances of getting better.
Methodology
The review discusses various studies on the extent of lymphadenectomy and its impact on patient outcomes.
Potential Biases
Variability in surgical practices and patient demographics may affect outcomes.
Limitations
The optimal number of lymph nodes to remove and the boundaries of lymphadenectomy are still debated.
Participant Demographics
Patients undergoing radical cystectomy for invasive bladder cancer.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website